Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-09-26
1997-07-01
Criares, Theodore J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514456, 514255, 514392, 5142355, 514337, 540484, A61K 3144, A61K 3135, A61K 31495, A61K 31535
Patent
active
056439210
ABSTRACT:
In accordance with the present invention novel methods for cardiopulmonary bypass and organ transplant, each employing a potassium channel activator, are disclosed. The use of a potassium channel activator has been found to reduce the damage or ischemia induced by the bypass and transplant procedures.
REFERENCES:
patent: 4975444 (1990-12-01), Danilewicz et al.
patent: 5011837 (1991-04-01), Atwal
patent: 5032591 (1991-07-01), Evans et al.
patent: 5061813 (1991-10-01), Atwal et al.
patent: 5140031 (1992-08-01), Atwal et al.
F. Gharagozloo et al., J. of Thoracic and Cardiovascular Surgery, vol. 77, No. 4, Apr. 1979, pp. 602-607.
F. Gharagozloo et al., Cardiac Transplantation, vol. 76, (supp V), Nov. 1987, pp. V-65 to V-70.
H. Kohno et al., J. Thorac. Cardiovasc. Surg., vol. 93, No. 1, Jan. 1987, pp. 86-94.
GA: vol. 105 (1986): 91027(8) Sakamoto.
Criares Theodore J.
E.R. Squibb & Sons, Inc.
Furman Jr. Theodore R.
Park Ellen K.
LandOfFree
Cardiopulmonary bypass and organ transplant using a potassium ch does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cardiopulmonary bypass and organ transplant using a potassium ch, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cardiopulmonary bypass and organ transplant using a potassium ch will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-597427